Krystal Biotech shareholders approve all four proposals at 2026 annual meeting

Krystal Biotech, Inc.

Elected Krish S. Krishnan and Christopher Mason as Class III directors with ~89% and ~84% of votes cast.
Ratified KPMG as independent auditor for FY2026 with over 99.9% of votes in favor.
Advisory vote on named executive officer compensation passed with ~95.5% of votes cast.
Approved non-employee director compensation policy with ~90% of unaffiliated votes cast.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.